MedTrace Logo

Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)

NCT03635411 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-01-06

No results posted yet for this study

Summary

Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET) A phase I, randomized, double-blind, placebo-controlled, single institutional pilot trial investigating the impact of nicotinamide riboside/pterstilbene (BasisTM) on functional recovery after traumatic fall in elderly patients

.

Conditions

  • Recovery of Function

Interventions

DIETARY_SUPPLEMENT

Nicotinamide Riboside and Pterostilbene

Nicotinamide riboside and pterostilbene manufactured by Basis

DIETARY_SUPPLEMENT

Placebo

Sugar pill manufactured to mimic Basis supplement.

Sponsors & Collaborators

Principal Investigators

  • Carrie Sims · Univeristy of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-06
Primary Completion
2020-11-30
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03635411 on ClinicalTrials.gov